Forum for Science, Industry and Business
  • Sponsored by:
  • Siemens
  • Siemens
  • Siemens
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

Bronchiolitis – best practice summed up

next article
19.12.2006

An “umbrella review” published in the latest edition of Evidence-Based Child Health: A Cochrane Review Journal neatly summaries the evidence base for the various treatment options for bronchiolitis. The review highlights the lack of treatment for a frequently experienced illness, and points to the urgent need for research.

 

What is bronchiolitis?


Bronchiolitis is the most common severe lower respiratory infection in infants. It occurs when a viral infection causes infants’ lower airways to become inflamed. They have difficulty breathing, sleeping and feeding.

What is its incidence?

Bronchiolitis affects 10-20% of infants under the age of two. Three percent of these are admitted to hospital, meaning that around 1.8 million infants are taken to US hospitals each year. Of these, 2.7% need intensive care, 1.5% need ventilation and 0.2% die.

Clinical comment

If there is no respiratory distress, feeding difficulties or specific risk factors, the infant can be treated at home with advice on when to return for re-assessment. If there are respiratory problems infants should be hospitalized and clinical treatment is normally limited to ensuring the infant is given adequate fluids, and oxygen. This can allow time for the infant to recover. Nebulised epinephrine may produce marginal relief, and could help some infants go home. The effect, however, is mild.

Various treatments have been tried in patients who are more severely affected, but none produce any marked effects. Bronchodilators and epinephrine produce no benefits, though some people suggest they may reduce restlessness and sleeplessness. Similarly, neither injecting steroids or immunoglobulins, nor giving vibration or percussive physiotherapy reduces symptoms.

A clear need for research

“What we need is a large randomised trial that carefully studies all of the currently available therapies and sees whether adjusting dose, type or frequency of treatment can produce greater benefit – then we need to examine new-comers,” says Dr. Michael Smith, author of the review, who works in the Department of Paediatrics, Craigavon Area Group Hospital Trust, Craigavon, Northern Ireland.

Evidence-Based Child Health: A Cochrane Review Journal is available online via Wiley InterScience, the online content service at: www.evidence-basedchildhealth.com

Polly Young | Source: alphagalileo
Further information: www.evidence-basedchildhealth.com

next article

More articles from Health and Medicine:

nachricht Does hormone treatment predispose patients to breast cancer?
21.11.2008 | CNRS (Délégation Paris Michel-Ange)

nachricht Mechanisms of cardiovascular disease and cancer give clues to new therapies
21.11.2008 | European Science Foundation

B2B Search

Product / Service
Company / Organisation

Latest News

Sustainable garden roofs developed as a new construction material

21.11.2008 | Studies and Analyses

Bees declared the winners in Earthwatch’s ‘irreplaceable species’ battle

21.11.2008 | Ecology, The Environment and Conservation

Hairspray is linked to common genital birth defect

21.11.2008 | Studies and Analyses

Event News

The Automobile – The Transition from Energy Guzzler to Power Supplier

20.11.2008 | Event News

Ministers meet to define the role of space in delivering global objectives

18.11.2008 | Event News

156th Annual Acoustical Society of America (ASA) Meeting in Miami

28.10.2008 | Event News